Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients

NCT01431924 · clinicaltrials.gov ↗

COMPLETED

Status

7779

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Higher-dose inhaled corticosteroids
DRUG: Low-dose fixed dose fluticasone propionate/salmeterol xinafoate combination

Sponsor

GlaxoSmithKline